Wistar Institute HIV Researchers Win Grant to Explore Genetically Engineered Natural Killer Cells as HIV Therapy
19 janv. 2023 14h44 HE | The Wistar Institute
PHILADELPHIA, PA, Jan. 19, 2023 (GLOBE NEWSWIRE) -- amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a...
Wistar Institute’s Maureen Murphy Named Deputy Director of the Ellen and Ronald Caplan Cancer Center
13 janv. 2023 09h18 HE | The Wistar Institute
PHILADELPHIA, PA, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Maureen Murphy, Ph.D., has been named Deputy Director of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute. Murphy will guide the...
Collaboration Advances DNA-delivered Antibodies to Prevent COVID-19
07 juil. 2022 10h00 HE | The Wistar Institute
Philadelphia, PA, July 07, 2022 (GLOBE NEWSWIRE) -- PHILADELPHIA — (July 7, 2022) — Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical,...
Ellen and Ronald Caplan.jpg
The Wistar Institute Cancer Center to be Renamed with $10 Million Gift from Caplan Family to Advance Cancer Research
08 mars 2022 13h00 HE | The Wistar Institute
Philadelphia, March 08, 2022 (GLOBE NEWSWIRE) -- The Wistar Institute announces that Ronald Caplan, founder and president of PMC Property Group, Inc., and his wife Ellen have donated $10 million to...
Wistar Reports New Class of Antibiotics Active Against a Wide Range of Bacteria
23 déc. 2020 11h23 HE | The Wistar Institute
PHILADLEPHIA, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial...
DARPA and JPEO-CBRND Award $37.6M to The Wistar Institute and Collaborators at INOVIO, AstraZeneca, Penn, & Indiana University to Develop Innovative COVID-19 Treatment
15 déc. 2020 11h31 HE | The Wistar Institute
PHILADELPHIA, Dec. 15, 2020 (GLOBE NEWSWIRE) -- A team of scientists from The Wistar Institute, INOVIO, AstraZeneca, the Perelman School of Medicine at the University of Pennsylvania, and Indiana...